Valuation : TELES

Market Cap 12.84L 14.9L 12.04L 10.99L 20.7L 14Cr 20.77L 1.43Cr 55.73L 7.19Cr 55.95L 54.73L 24Cr P/E 2024
-4.29x
P/E 2025 -4.4x
Enterprise Value 49.79L 57.78L 46.68L 42.61L 80.28L 55Cr 80.53L 5.54Cr 2.16Cr 28Cr 2.17Cr 2.12Cr 92Cr EV / Sales 2024
19.8x
EV / Sales 2025 90.1x
Free-Float
26.91%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/01/2024
Director TitleAgeSince
Chairman - -
Director/Board Member - 12/08/2019
Director/Board Member - 12/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 14.9L
-0.06%-4.11%-11.28%+20.94% 22TCr
+1.36%+1.31%+14.05%+49.33% 21TCr
+1.17%-1.45%-9.11%+46.54% 16TCr
+0.24%+1.51%+7.18%+1.26% 8.58TCr
-0.41%-0.31%-16.61%+30.56% 8.13TCr
-0.85%-1.69%+5.26%+25.24% 6.98TCr
+0.13%+1.18%+6.33%+10.82% 5.94TCr
-0.22%+2.27%+5.13%+91.10% 5.79TCr
-0.37%-0.09%+19.40%+8.90% 5.1TCr
Average +0.10%-0.26%+2.26%+31.63% 11.06TCr
Weighted average by Cap. +0.36%-0.75%+0.25%+33.21%

Financials

2024 2025
Net sales 2L 2L 2L 2L 3L 2.3Cr 3L 23.04L 9L 1.16Cr 9L 9L 3.84Cr 68.54T 79.54T 64.26T 58.66T 1L 76.02L 1L 8L 3L 38.37L 3L 3L 1.27Cr
Net income -8L -10L -8L -7L -13.47L -9.27Cr -13.52L -92.95L -36.26L -4.68Cr -36.41L -35.61L -16Cr -6L -7L -5L -5L -9L -6.25Cr -9L -62.72L -24.47L -3.16Cr -24.57L -24.03L -10Cr
Net Debt 5L 6L 5L 4L 8L 5.66Cr 8L 56.77L 22.15L 2.86Cr 22.24L 21.75L 9.47Cr 36.95L 42.88L 34.64L 31.62L 59.57L 41Cr 59.76L 4.11Cr 1.6Cr 21Cr 1.61Cr 1.57Cr 69Cr
Logo TELES
Arzneiwerk VIDA AG, formerly Teles AG, is a Germany-based financial holding company. The Company is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. It focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
Employees
-